Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Degradation of extracellular matrix molecules in interleukin-1α treated bovine nasal cartilage.

Shohani B, Orazizadeh M, Hashemitabar M, Heinegard D.

Iran Biomed J. 2010 Oct;14(4):158-63.

PMID:
21283258
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Fragmentation of proteins in cartilage treated with interleukin-1: specific cleavage of type IX collagen by matrix metalloproteinase 13 releases the NC4 domain.

Danfelter M, Onnerfjord P, Heinegård D.

J Biol Chem. 2007 Dec 21;282(51):36933-41. Epub 2007 Oct 19.

PMID:
17951262
[PubMed - indexed for MEDLINE]
Free Article
3.

Cleavage of cartilage oligomeric matrix protein (thrombospondin-5) by matrix metalloproteinases and a disintegrin and metalloproteinase with thrombospondin motifs.

Dickinson SC, Vankemmelbeke MN, Buttle DJ, Rosenberg K, Heinegård D, Hollander AP.

Matrix Biol. 2003 May;22(3):267-78.

PMID:
12853037
[PubMed - indexed for MEDLINE]
5.

Combination effects of prednisolone and interleukin-4 protect bovine nasal cartilage explants from interleukin-1α induced degradation.

Yadegari M, Orazizadeh M, Hashemitabar M, Khodadadi A.

Iran Biomed J. 2011;15(4):143-50.

PMID:
22395139
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP).

Stracke JO, Fosang AJ, Last K, Mercuri FA, Pendás AM, Llano E, Perris R, Di Cesare PE, Murphy G, Knäuper V.

FEBS Lett. 2000 Jul 28;478(1-2):52-6.

PMID:
10922468
[PubMed - indexed for MEDLINE]
Free Article
7.

Resistance of small leucine-rich repeat proteoglycans to proteolytic degradation during interleukin-1-stimulated cartilage catabolism.

Sztrolovics R, White RJ, Poole AR, Mort JS, Roughley PJ.

Biochem J. 1999 May 1;339 ( Pt 3):571-7.

PMID:
10215595
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.

Billinghurst RC, Wu W, Ionescu M, Reiner A, Dahlberg L, Chen J, van Wart H, Poole AR.

Arthritis Rheum. 2000 Mar;43(3):664-72.

PMID:
10728761
[PubMed - indexed for MEDLINE]
Free Article
9.

Cleavage of fibromodulin in cartilage explants involves removal of the N-terminal tyrosine sulfate-rich region by proteolysis at a site that is sensitive to matrix metalloproteinase-13.

Heathfield TF, Onnerfjord P, Dahlberg L, Heinegård D.

J Biol Chem. 2004 Feb 20;279(8):6286-95. Epub 2003 Dec 3.

PMID:
14660626
[PubMed - indexed for MEDLINE]
Free Article
11.

Type II and VI collagen in nasal and articular cartilage and the effect of IL-1alpha on the distribution of these collagens.

Jansen ID, Hollander AP, Buttle DJ, Everts V.

J Mol Histol. 2010 Feb;41(1):9-17. doi: 10.1007/s10735-010-9257-7. Epub 2010 Mar 6.

PMID:
20213143
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Protective effects of interleukin-4 on tissue destruction and morphological changes of bovine nasal chondrocytes in vitro.

Yadegari M, Orazizadeh M, Hashemitabar M, Khodadadi A.

Iran Biomed J. 2013;17(4):187-93.

PMID:
23999714
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Production of cartilage oligomeric matrix protein (COMP) by cultured human dermal and synovial fibroblasts.

Dodge GR, Hawkins D, Boesler E, Sakai L, Jimenez SA.

Osteoarthritis Cartilage. 1998 Nov;6(6):435-40.

PMID:
10343777
[PubMed - indexed for MEDLINE]
Free Article
14.

Cartilage degradation independent of MMP/aggrecanases.

Sugimoto K, Iizawa T, Harada H, Yamada K, Katsumata M, Takahashi M.

Osteoarthritis Cartilage. 2004 Dec;12(12):1006-14.

PMID:
15564068
[PubMed - indexed for MEDLINE]
Free Article
15.

Combined role of type IX collagen and cartilage oligomeric matrix protein in cartilage matrix assembly: cartilage oligomeric matrix protein counteracts type IX collagen-induced limitation of cartilage collagen fibril growth in mouse chondrocyte cultures.

Blumbach K, Bastiaansen-Jenniskens YM, DeGroot J, Paulsson M, van Osch GJ, Zaucke F.

Arthritis Rheum. 2009 Dec;60(12):3676-85. doi: 10.1002/art.24979.

PMID:
19950300
[PubMed - indexed for MEDLINE]
Free Article
16.

Morphological changes of bovine nasal chondrocytes induced by interleukin-1α.

Yadegari M, Orazizadeh M, Hashemitabar M, Khodadadi A.

Cell J. 2013 Spring;15(1):19-28. Epub 2013 May 5.

PMID:
23700557
[PubMed]
Free PMC Article
17.

N-terminal sequence of proteoglycan fragments isolated from medium of interleukin-1-treated articular-cartilage cultures. Putative site(s) of enzymic cleavage.

Loulakis P, Shrikhande A, Davis G, Maniglia CA.

Biochem J. 1992 Jun 1;284 ( Pt 2):589-93.

PMID:
1599440
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Differential effects of interleukin-1 on hyaluronan and proteoglycan metabolism in two compartments of the matrix formed by articular chondrocytes maintained in alginate.

D'Souza AL, Masuda K, Otten LM, Nishida Y, Knudson W, Thonar EJ.

Arch Biochem Biophys. 2000 Feb 1;374(1):59-65.

PMID:
10640396
[PubMed - indexed for MEDLINE]
19.

Effect of IL-1alpha on the expression of cartilage matrix proteins in human chondrosarcoma cell line OUMS-27.

Aida Y, Maeno M, Ito-Kato E, Suzuki N, Shiratsuchi H, Matsumura H.

Life Sci. 2004 Nov 12;75(26):3173-84.

PMID:
15488896
[PubMed - indexed for MEDLINE]
20.

Arthritis and cannabinoids: HU-210 and Win-55,212-2 prevent IL-1alpha-induced matrix degradation in bovine articular chondrocytes in-vitro.

Mbvundula EC, Bunning RA, Rainsford KD.

J Pharm Pharmacol. 2006 Mar;58(3):351-8.

PMID:
16536902
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk